Entresto Europeiska unionen - ungerska - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, a valzartán - szív elégtelenség - az angiotenzin ii antagonisták, más kombinációk, ható, a renin-angiotenzin rendszer - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Ketoconazole HRA Europeiska unionen - ungerska - EMA (European Medicines Agency)

ketoconazole hra

hra pharma rare diseases - ketokonazol - cushing szindróma - szisztémás felhasználású antimikotikumok - a ketokonazol hra kifejeződik az endogén cushing-szindróma kezelésére 12 évesnél idősebb felnőtteknél és serdülőknél.

Neparvis Europeiska unionen - ungerska - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, a valzartán - szív elégtelenség - a renin-angiotenzin rendszerre ható szerek - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Copiktra Europeiska unionen - ungerska - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - daganatellenes szerek - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.